l.georges online

work ‘n’ shit

Archive for the ‘FASM2’ Category

November 22nd, 2016 by admin

FASM2 organisation

Une heure hebdomadaire:

Groupes 1,2 & 3 (Mme Mutin) et groupes 4,5 & 6 (Mme Georges) à 9h, 10h et 12h respectivement les lundi 21 et 28 novembre, le 5 décembre, 20 et 27 février, 6, 13, 20 et 27 mars, et le jeudi 18 mai. Le contrôle aura lieu le 29 mai.

Groupes 8, 9 & 10 (Mme Mutin) et groupes 7, 11 et 12 (Mme Georges) à 9h, 10h et 12h respectivement les mardi 22 et 29 novembre, le 6 décembre, 21 et 28 février, 7, 14, 21 et 28 mars, et le vendredi 19 mai. Le contrôle aura lieu le 30 mai.

Groupes 13 & 14 (Mme Georges) 13h et 14h respectivement les vendredi le 25 novembre,  2 & 9 décembre, 24 février, 3, 10, 17, 24 et 31 mars, 19mai. Le contrôle aura lieu le 2 juin.

Pour tout changement ponctuel, merci de bien vouloir contacter votre enseignant au préalable.


September 29th, 2016 by admin

FASM2 session 1 links

Research questions

Further information  on RQs

Bibliometrics tools

http://eigenfactor.org/projects.php (network analysis applied to citation reports)

https://www.journalmetrics.com/ (Elsevier tool)

http://www.harzing.com/resources/publish-or-perish (based on GS data)





March 25th, 2016 by admin

Questions sur l’article

Voici un document contenant des éléments de réponse pour les questions vues cette semaine pour l’article : Jindal et al., “Comparison of short term results of single injection of autologous blood and steroid injection in tennis elbow: a prospective study”,  Journal of Orthopaedic Surgery and Research 2013, 8:10

March 23rd, 2016 by admin

Critique d’articles

Un article très intéressant sur la p-value : The P-Value is a hoax, and here’s how to fix it.

March 21st, 2016 by admin

Article complémentaire – Tennis Elbow

Vous pouvez télécharger un article complémentaire sur l’épicondylite ici.  L’étude est très similaire à celle décrite dans l’article que nous avons vu ensemble, mais vous donne plus de détails sur les outils de mesure, notamment l’échelle de Nirschl.

January 25th, 2016 by admin

FASM2 Session 2 links

Literature review



Keyword development


Reference extraction



www.ukdataservice.ac.uk – datasets (registration required) from cohorts

Data.gov & healthdata.gov – US datasets, most of which are publicly available

http://www.mortality.org – The human mortality database

www.kdnuggets.com/datasets/index.html – includes some health-related resources

Text analysis

http://www.tapor.ca/ – directory

http://textometrie.ens-lyon.fr/ – TXM free

https://gate.ac.uk/ – open source

Data analysis/Statistics

JASP – https://jasp-stats.org/

SOFA – http://www.sofastatistics.com/home.php – advertised as user-friendly




September 24th, 2015 by admin

FASM2 – Article 1

Voici le premier article en version pdf : Cardiovascular & cerebrovascular effects in response to Red Bull…

March 6th, 2015 by admin

Proposition d’abstract structuré


Tumor associated antigens (TAAs) have shown potential in the detection of cancers, but low sensitivity hampers their usefulness.  We sought to discover whether an array of TAAs might improve autoantibody detection, and make them a more useful diagnostic tool.


A panel of TAAs, including Imp1, p62, Koc, p53, C-myc, Cyclin B1, Survivin, and p16 full-length recombinant proteins, was used to test sera from 304 cancer patients and 58 normal individuals, by enzyme-linked immunoassay and western blotting.


The frequency of autoantibodies to a single TAA varied according to the type of cancer, yet generally remained below 20%.  Successive addition of TAAs led to a stepwise increase, the degree of which varied between types of cancer, but the combined mini-array of 8 TAAs produced a frequency of between 56.1% and 66.0% for cancers and only 13.8% in serum from healthy individuals.


Our results support the hypothesis that using a combined mini-array can further enhance the immunodiagnosis of cancer based on the detection of anti-TAA antibodies. The design of specific TAA arrays for different types of cancer may lead to better sensitivity rates, and it may even be possible to use such panels for early detection in high-risk individuals.